ADVERTISEMENT

Patanjali Group Is Planning Four IPOs In Next Five Years

Currently, Patanjali Foods is the only group company that’s listed on the stock market.

<div class="paragraphs"><p> Patanjali Ayurved founders Swami Ramdev and Acharya Bal Krishna.</p></div>
Patanjali Ayurved founders Swami Ramdev and Acharya Bal Krishna.

Patanjali Group plans to list four of its companies in the next five years as it aims to have a market capitalisation of more than Rs 5 lakh crore.

This will include Patanjali Ayurved, Patanjali Wellness, Patanjali Lifestyle, and Patanjali Medicine, according to a person in the know.

At present, Patanjali Foods Ltd. is the only group company that’s listed on the stock market. Its initial public offering, however, did not come under the leadership of Ramdev. The company, listed as Ruchi Soya, was bought by Patanjali Ayurved in 2019 for Rs 4,350 crore under a resolution process.

Patanjali Group, in a media statement, said Ramdev will address a press conference on Sept. 16 in New Delhi to outline the company’s ‘Vision & Mission 2027’, detail the group’s five major goals over the next five years and brief about the IPOs. He also plans “to expose conspiracies and efforts of rumour-mongers who spread false facts and figures with vested motives to disparage Patanjali and its Swadeshi Movement in the direction of stronger and healthier India”, the release said.

The Haridwar-based company reported a consolidated net profit of Rs 740.4 crore in FY22 compared with Rs 745 crore in FY21, according to an exchange filing. Revenue rose 8.7% to Rs 10,664.5 crore in FY22.

Founded in 2006, Patanjali Ayurved manufactures cosmetics, ayurvedic medicine, personal care and food products. Diversifying from the edible oil business, Patanjali’s aggressive entry into the fast-moving consumer goods market in 2015 was seen as a major disruptor forcing top local and foreign FMCG brands to launch their own ayurvedic and natural products.

In less than three years since the Patanjali Group acquired Ruchi Soya under the insolvency process, it has led an encouraging turnaround. It consolidated its position after acquiring the entire foods business with over 500 stock-keeping units across eight product categories, including ghee, honey, spices, juices and atta, along with all the manufacturing facilities from Patanjali Ayurved for Rs 690 crore. In May 2021, it had also acquired biscuits, cookies and rusk businesses, and the breakfast cereals and noodles business in June 2021.

The FMCG business revenue rose to Rs 9,241 crore in FY22 from Rs 8,778 crore in FY21, while ayurvedic products business rose to Rs 1,274 crore from Rs 925 crore in FY21, according to its exchange filing.